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Molecular dockingAbstract A green multicomponent one pot synthesis of novel 2-(1H-indol-3-ylmethyl)-5,
5-dimethyl-cyclohexane-1,3-diones (4a–l) in excellent yields was conveniently carried out in aqueous
medium at room temperature over mpCuO as heterogeneous catalyst. The synthesised 3-alkylated
indoles were characterised by FTIR, 1H NMR, 13C NMR and HRLCMS. The nanocatalyst was
facially synthesised via a green sol–gel route and characterised by SEM, TEM, EDX, PXRD,
BET and FTIR. The porous nanocatalyst can be recycled ﬁve times without signiﬁcant drop in pro-
duct yield. Docking studies against enoyl acyl carrier protein reductase predicts that the compounds
bind at the active site with high binding afﬁnity values. The compound 4k (MIC, 15 lg/mL) shows
comparable activity in reference to Isoniazid at the same concentrations against MT H37 Rv.
 2016 King Saud University. Production and Hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Natural products are the main source of motivation to design
and synthesise new molecules for drug development. Most of
these natural products consist of a heterocyclic core. Amongst
nitrogen containing heterocycles, indole is a ubiquitous struc-
tural unit of a number of natural products like rutaecarpine,
horsﬁline, spirotryprostatin B, cryptosanguinolentine etc.
Indole moiety has been employed in the designing of new hete-
rocyclic compounds with diverse biological and pharmacolog-
ical properties like antimicrobial, antitubercular, antimalarial,Journal
2 G.A. Khan et al.antitubulin, sodium-glucose cotransporter-2 inhibitors, antiox-
idant and ﬂuorescent metal probes to sense molecular recogni-
tions [1–7]. However, indole derivatives bearing ferrocene
moiety and carboxylate chains have been found to exhibit
potent anticancer, cytotoxic and antiviral [1,8–11] properties.
Multi-component reactions (MCRs) are of immense impor-
tance in the ﬁeld of medicinal chemistry. MCRs favour molec-
ular diversity to be generated by mixing simple precursors by
facile creation of several new bonds in a single-step transfor-
mation with no need of intermediate isolation and their puriﬁ-
cation quite ultimately affords a desirable complex product
[9,11–13]. High atom-economy, mild conditions, structural
complexity and environmentally benign synthesis of some
valuable heterocyclic scaffolds are one of the most advanta-
geous features encountered in MCRs [14].
Heterogeneous catalysis in water as a solvent is regarded as
green and sustainable approach. As a consequence, synthetic
chemists prefer to design MCRs in water over potentially toxic
non-aqueous organic solvents to reduce chemical impurity, to
allow easy work-up as a consequence of its ideal behaviour.
Water is known to enhance the rate and selectivity of organic
transformations due to the interactions like hydrogen bonding,
hydrophobic effect and trans-phase interactions [15,16]. Water
also tends to have many practical and economic advantages as
a reaction solvent, including low cost, inﬂammable and high
speciﬁc heat capacity which renders it one of the safest medi-
ums speciﬁcally for exothermic transformations [17].
The fusion of a benign aqueous medium and nano-catalyst
seems to be a fascinating way to explore the next generation of
green and efﬁcient protocols. Because of its high surface area
and maximum active sites, nanomaterials exhibit excellent cat-
alytic activities compared with the corresponding bulk materi-
als [18]. In this regard, the searching for a method to
incorporate moieties like indole and dimedone to construct a
valuable heterocyclic scaffold by nanocatalytic one pot reac-
tion in water should be strongly desired.
The synthesis of 3-substitted indoles via Knoevenagel/
Michael reaction is found to be atom efﬁcient and thus are
inherently green transformations [19]. The reaction has been
traditionally accomplished with various basic catalysts/
reagents, like NaOH [20], and Mg–Al–O–t-Bu hydrotalcite
[21]. Under these strong basic conditions side reactions, such
as aldol addition, polymerizations, and rearrangements, were
frequently observed [22]. Recently, various Lewis and Bron-
sted acid catalysts such as InBr3 [23], [Al(DS)3]3H2O [24],
FeCl3 [25], CeCl37H2O–NaI [26], SmI3 [27], and K10–FeO
[28], and metal salts have been used [29]. However, some of
the reported protocols with homogeneous catalysts suffer from
severe disadvantages such as strong acidic conditions, compli-
cate work-up procedures, expensive reagents, inadequate
yields, and long reaction time.
MCRs assisted by recyclable nanocatalysts under green
reaction conditions present an efﬁcient tool for the sustainable
synthesis of heterocycles [30]. Nanocrystalline metal oxides of
Zn and Mg have been used to catalyse green organic transfor-
mations in water [13,31]. However, it is interesting to note that
the addition of low levels of Cu as a promoter to ZnS nanopar-
ticles (ZnS NPs) has improved the catalytic activity sevenfold
higher than ZnS NPs alone [17]. Doping with copper intro-
duced measurable changes in the surface and catalytic systemPlease cite this article in press as: G.A. Khan et al., Porous CuO catalysed green synt
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recyclable heterogeneous catalyst under benign reaction
conditions.
With this background, and as a part of our on-going
research towards green chemistry and nanocatalysis, we herein
report a facile one-pot synthesis of a novel series of
2-(1H-indol-3-ylmethyl)-5,5-dimethyl-cyclohexane-1,3-diones
4a–l (Scheme 1) using mpCuO as a reusable heterogeneous cat-
alyst in water. The antitubercular nature of synthesised com-
pounds was determined by means of disc diffusion assay.
Amongst the various targets for anti TB drugs, enoyl-acyl car-
rier protein (ACP) reductase being a well established target
[32,33] was selected as the target for docking simulations.
ACP reductase is a key enzyme for the synthesis of the type
II fatty acids.
2. Experimental
2.1. Chemicals and apparatus
Sigma–Aldrich, CDH and Merck purchased chemicals were
used without puriﬁcation to carry out this work. Melting
points were determined using open capillary tube melting point
apparatus and are presented without any correction. The infra-
red (IR) spectra were recorded on a FTIR Shimadzu-8400S
spectrometer using KBr pellets. The 1H NMR and 13C
NMR spectra were recorded on Bruker Avance 400 spectrom-
eter using tetramethylsilane (TMS) as the internal standard
and CDCl3 as solvent. HRLCMS were determined on Bruker
Microtoff-QII 10330 mass spectrometer. The purity of the
compounds was checked by TLC using Merck pre-coated silica
gel GF aluminium plates.
2.2. General one pot synthesis of 2-(1H-indol-3-ylmethyl)-5,5-
dimethyl-cyclohexane-1,3-diones (4a-l)
A mixture of indole (1 mmol), dimedone (1 mmol) and substi-
tuted aldehyde (1 mmol) in 10 ml water in the presence of
0.04 mmol mpCuO (Supplementary S1–S6) as a heterogeneous
catalyst was stirred at room temperature till the completion of
reaction (checked by TLC). The resulting solid compound was
ﬁltered off and then treated with DMF. The mixture was cen-
trifuged at 2500 rpm for some time to recover mpCuO parti-
cles. The organic solution was then poured into water, and
ﬁltered and recrystallized from ethanol followed by drying
under vacuum to afford the pure product (Scheme 1).
2.2.1. 2-[(4-Chloro-phenyl)-(1H-indol-3-yl)-methyl]-5,5-
dimethyl-cyclohexane-1,3-dione (4a)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3045 (CH), 1717
(C‚O), 1547 (C‚C), 1320 (C–N), 822 (C–Cl). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s,
4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3 (s, 1H, HAr),
6.9 (d, J= 8 Hz, 2H, HAr), 7.0 (dd, J1 = 8 Hz &
J2 = 7.2 Hz, 1H, HAr), 7.2 (dd, J1 = 7.2 Hz & J2 = 6.8 Hz,
1H, HAr), 7.5 (d, J= 3.6 Hz, 2H, HAr), 7.6 (d, J= 6.4 Hz,
1H, HAr), 7.8 (d, J= 10.4 Hz, 1H, HAr), 9.4 (s, 1H, NH);
13C NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9,
58.8, 68.7, 109.3, 111.3, 115.3, 116.6, 116.8, 117.84, 118.8,hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
Scheme 1 Green mpCuO catalysed one pot three component reaction of indole, aldehyde and dimedone.
3-Alkylated indole derivatives as antitubercular agents 3124.4, 126.7, 127.9, 128.3, 131.1, 143.4, 169.7; HRLCMS
(ESI): m/z [M+H]+: 380.1412.2.2.2. 2-[(1H-indol-3-yl)-phenyl-methyl]-5,5-dimethyl-
cyclohexane-1,3-dione (4b)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3073 (CH), 1707
(C‚O), 1537 (C‚C), 1320 (C–N). 1H NMR (400 MHZ,
CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s, 4H, CH2), 3.7
(s, 1H, CH), 4.6 (s, 1H, CH), 6.3 (s, 1H, HAr), 6.8 (m, 5H,
HAr), 7.0 (dd, J1 = 8 Hz & J2 = 7.2 Hz, 1H, HAr), 7.2 (dd,
J1 = 7.2 Hz & J2 = 6.8 Hz, 1H, HAr), 7.6 (d, J= 6.4 Hz,
1H, HAr), 7.8 (d, J= 10.4 Hz, 1H, HAr), 9.4 (s, 1H, NH);
13C NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9,
58.8, 68.7, 109.3, 111.3, 115.3, 116.6, 116.8, 117.84, 118.8,
121, 122.3, 124.4, 128.3, 131.1, 145, 169.7; HRLCMS (ESI):
m/z [M+H]+: 346.1812.2.2.3. 2-[(3-Nitro-phenyl)-(1H-indol-3-yl)-methyl]-5,5-
dimethyl-cyclohexane-1,3-dione (4c)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3070 (CH), 1707
(C‚O), 1546 (C‚C), 1371 (N–O), 1320 (C–N). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s,
4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3 (s, 1H, HAr),
7.0 (dd, J1 = 8 Hz & J2 = 7.2 Hz, 1H, HAr), 7.2 (dd,
J1 = 7.2 Hz & J2 = 6.8 Hz, 1H, HAr), 7.4 (dd, J= 4.6 Hz,
1H, HAr), 7.5 (d, J= 7.6 Hz, 1H, HAr), 7.6 (d, J= 6.4
Hz, 1H, HAr), 7.8 (d, J= 10.4 Hz, 1H, HAr), 7.9 (d,
J= 3.2 Hz, 1H, HAr), 8.0 (d, J= 7.6 Hz, 2H, HAr), 9.4 (s,
1H, NH); 13C NMR (125 MHZ, CDCl3, d ppm) dc: 17.9,
23.9, 36.9, 58.8, 68.7, 109.3, 111.3, 115.3, 115.7, 116.6, 116.8,
117, 117.84, 118.8, 128.3, 130, 131.1, 143.4, 143.5, 145.7, 147,
169.7; HRLCMS (ESI): m/z [M+H]+: 391.1712.2.2.4. 2-[(4-Nitro-phenyl)-(1H-indol-3-yl)-methyl]-5,5-
dimethyl-cyclohexane-1,3-dione (4d)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3078 (CH), 1707
(C‚O), 1558 (C‚C), 1371 (N–O), 1320 (C–N). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4
(s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3 (s, 1H,
HAr), 7.0 (dd, J1 = 8 Hz & J2 = 7.2 Hz, 1H, HAr), 7.2 (dd,
J1 = 7.2 Hz & J2 = 6.8 Hz, 1H, HAr), 7.4 (d, J= 6.8 Hz,
2H, HAr), 7.6 (d, J= 6.4 Hz, 1H, HAr), 7.8 (d, J= 10.4 Hz,
1H, HAr), 8.1 (d, J= 4.4 Hz, 2H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9, 45.5,
58.8, 68.7, 109.3, 111.3, 115.3, 116.5, 116.6, 116.8, 117.84,
118.8, 124.7, 126.7, 128.3, 131.1, 147, 169.7; HRLCMS
(ESI): m/z [M+H]+: 391.1712.Please cite this article in press as: G.A. Khan et al., Porous CuO catalysed green synt
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dimethyl-cyclohexane-1,3-dione (4e)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3070 (CH), 1707
(C‚O), 1546 (C‚C), 1320 (C–N), 1293 (C–O). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s,
4H, CH2), 3.6 (s, 3H, CH3), 3.7 (s, 1H, CH), 4.6 (s, 1H,
CH), 6.1 (d, J= 4.4 Hz, 2H, HAr), 6.3 (s, 1H, HAr), 7.01 (d,
J= 7.6 Hz, 2H, HAr), 7.0 (dd, J1 = 8 Hz & J2 = 7.2 Hz,
1H, HAr), 7.2 (dd, J1 = 7.2 Hz & J2 = 6.8 Hz, 1H, HAr), 7.6
(d, J= 6.4 Hz, 1H, HAr), 7.8 (d, J= 10.4 Hz, 1H, HAr), 9.4
(s, 1H, NH); 13C NMR (125 MHZ, CDCl3, d ppm) dc: 17.9,
23.9, 36.9, 58.8, 68.7, 109.3, 111.3, 115.3, 114,116.6, 116.8,
117.84, 118.8, 128.3, 128.9, 131.1, 132.5, 159.2 169.7;
HRLCMS (ESI): m/z [M+H]+: 376.1912.
2.2.6. 2-[1-(1H-indol-3-yl)-ethyl]-5,5-dimethyl-cyclohexane-
1,3-dione (4f)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 2972 (CH), 1707
(C‚O), 1546 (C‚C), 1320 (C–N), 1293 (C–O). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 1.4 (s,
3H, CH3), 2.4 (s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H,
CH), 6.3 (s, 1H, HAr), 7.0 (dd, J1 = 8 Hz & J2 = 7.2 Hz,
1H, HAr), 7.2 (dd, J1 = 7.2 Hz & J2 = 6.8 Hz, 1H, HAr), 7.6
(d, J= 6.4 Hz, 1H, HAr), 7.8 (d, J= 10.4 Hz, 1H, HAr), 9.4
(s, 1H, NH); 13C NMR (125 MHZ, CDCl3, d ppm) dc: 15.3,
17.9, 21, 23.9, 36.9, 58.8, 68.7, 109.3, 111.3, 115.3, 116.6,
116.8, 117.84, 118.8, 128.3, 131.1, 169.7; HRLCMS (ESI):
m/z [M+H]+: 284.1712.
2.2.7. 2-[(5-Bromo-1H-indol-3-yl)-(4-chloro-phenyl)-methyl]-
5,5-dimethyl-cyclohexane-1,3-dione (4g)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3053 (CH), 1717
(C‚O), 1547 (C‚C), 1320 (C–N), 822 (C–Cl), 658 (C–Br).
1H NMR (400 MHZ, CDCl3, TMS, d ppm, J=Hz): 1.2 (s,
6H, CH3), 2.4 (s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H,
CH), 6.3 (s, 1H, HAr), 6.9 (d, J= 8 Hz, 2H, HAr), 7.3 (d,
J= 3.2 Hz, 1H, HAr), 7.4 (d, J= 6.8 Hz, 1H, HAr), 7.5 (d,
J= 3.6 Hz, 2H, HAr), 7.7 (s, 1H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9, 58.8,
68.7, 110, 111.3, 116, 116.3, 123.4, 124, 124.4, 126.7, 127.9,
128, 131.8, 143.4, 169.7; HRLCMS (ESI): m/z [M+H]+:
460.0512.
2.2.8. 2-[(5-Bromo-1H-indol-3-yl)-phenyl-methyl]-5,5-
dimethyl-cyclohexane-1,3-dione (1h)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3073 (CH), 1707
(C‚O), 1537 (C‚C), 1320 (C–N), 658 (C–Br). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s,
4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3 (s, 1H, HAr),hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
Figure 1 Superimposition of docked conformation (pink) over
the co-crystallized conformation (yellow) of triclosan shows
RMSD value close to zero, conﬁrming the reliability of docking
4 G.A. Khan et al.6.8 (m, 5H, HAr), 7.3 (d, J= 3.2 Hz, 1H, HAr), 7.4 (d,
J= 6.8 Hz, 1H, HAr), 7.7 (s, 1H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9, 58.8,
68.7, 111.3, 116, 116.3, 120, 121, 122.3, 123.4, 124, 124.4,
128, 131.8, 145, 169.7; HRLCMS (ESI): m/z [M+H]+:
424.0912.
2.2.9. 2-[(5-Bromo-1H-indol-3-yl)-(3-Nitro-phenyl)-methyl]-
5,5-dimethyl-cyclohexane-1,3-dione (4i)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3081 (CH), 1707
(C‚O), 1546 (C‚C), 1371 (N–O), 1320 (C–N), 658 (C–Br).
1H NMR (400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H,
CH3), 2.4 (s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3
(s, 1H, HAr), 7.3 (d, J= 3.2 Hz, 1H, HAr), 7.4 (dd,
J= 4.6 Hz, 1H, HAr), 7.5 (d, J= 7.6 Hz, 1H, HAr), 7.7 (s,
1H, HAr), 7.9 (d, J= 3.2 Hz, 1H, HAr), 8.0 (d, J= 7.6 Hz,
2H, HAr), 9.4 (s, 1H, NH);
13C NMR (125 MHZ, CDCl3, d
ppm) dc: 17.9, 23.9, 36.9, 58.8, 68.7, 111.3, 115.7, 116, 116.3,
117, 120, 123.4, 124, 128, 130, 131.8, 143.4, 143.5, 145.7, 147,
169.7; HRLCMS (ESI): m/z [M+H]+: 470.0812.
2.2.10. 2-[(5-Bromo-1H-indol-3-yl)-(4-Nitro-phenyl)-methyl]-
5,5-dimethyl-cyclohexane-1,3-dione (4j)
FTIR (KBr) (Ѵmax cm
1): 3722 (N–H), 3075 (CH), 1707
(C‚O), 1546 (C‚C), 1371 (N–O), 1320 (C–N), 658 (C–Br).
1H NMR (400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H,
CH3), 2.4 (s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3
(s, 1H, HAr), 7.3 (d, J= 3.2 Hz, 1H, HAr), 7.4 (d,
J= 6.4 Hz, 2H, HAr), 7.4 (d, J= 6.8 Hz, 1H, HAr), 7.7 (s,
1H, HAr), 8.1 (d, J= 4.4 Hz, 2H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9, 45.5,
58.8, 68.7, 111.3, 116, 116.3, 116.5, 120, 123.4, 124.1, 124.7,
126.7, 128, 131.8, 147, 169.7; HRLCMS (ESI): m/z
[M+H]+: 470.0812.
2.2.11. 2-[(5-Bromo-1H-indol-3-yl)-(4-Methoxy-phenyl)-
methyl]-5,5-dimethyl-cyclohexane-1,3-dione (4k)
FTIR (KBr) (Ѵmax cm
1): 3725 (N–H), 3120 (CH), 1715
(C‚O), 1480 (C‚C), 822 (C–Cl), 717 (C–Br). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 2.4 (s,
4H, CH2), 3.6 (s, 3H, CH3), 3.7 (s, 1H, CH), 4.6 (s, 1H,
CH), 6.1 (d, J= 4.4 Hz, 2H, HAr), 6.3 (s, 1H, HAr), 7.01 (d,
J= 7.6 Hz, 2H, HAr), 7.3 (d, J= 3.2 Hz, 1H, HAr), 7.4 (d,
J= 6.8 Hz, 1H, HAr), 7.7 (s, 1H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 17.9, 23.9, 36.9, 58.8,
68.7, 111.3, 114, 116, 116.3, 120, 123.4, 124, 128, 128.9,
131.8, 132.5, 159.2 169.7; HRLCMS (ESI): m/z [M + H]+:
454.1012.
2.2.12. 2-[1-(5-Bromo-1H-indol-3-yl)-ethyl]-5,5-dimethyl-
cyclohexane-1,3-dione (4l)
FTIR (KBr) (Ѵmax cm
1): 3513 (OH), 1351 (N–O), 3026 (CH),
1700 (C‚O), 1645 (C‚C), 1348 (C–O), 1238 (C–N). 1H NMR
(400 MHZ, CDCl3, TMS, d ppm): 1.2 (s, 6H, CH3), 1.4 (s, 3H,
CH3), 2.4 (s, 4H, CH2), 3.7 (s, 1H, CH), 4.6 (s, 1H, CH), 6.3
(s, 1H, HAr), 7.3 (d, J= 3.2 Hz, 1H, HAr), 7.4 (d,
J= 6.8 Hz, 1H, HAr), 7.7 (s, 1H, HAr), 9.4 (s, 1H, NH);
13C
NMR (125 MHZ, CDCl3, d ppm) dc: 15.3, 17.9, 21, 23.9,
58.8, 68.7, 109, 111, 116, 116.3, 120, 123.4, 124, 128, 131.8;
HRLCMS (ESI): m/z [M+H]+: 362.0812.Please cite this article in press as: G.A. Khan et al., Porous CuO catalysed green synt
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2.3.1. Antitubercular activity
Mycobacterium tuberculosis bacterial strain (MTCC CODE
300) purchased from the Institute of Microbial Technology
(MTCC) Chandigarh (India), was cultured in blood nutrient
agar medium in late logarithmic (A600 nm = 1) fashion. Bacte-
rial strains possessing a plasmid adhering Isoniazid resistance
marker were cultured in the same medium containing
100 lg/mL Isoniazid. It was shortly followed by streaking of
0.5 lL bacterial spread on LB agar plates (25 mL agar med-
ium ± 90 lg/mL Isoniazid discs over 9 cm Petri plates) as con-
trol. Filter discs (5 mm diameter) of Whatman range were
treated with 5 lL of compound solutions including reference
(Isoniazid). After this, discs were air-dried for 7–10 min and
kept over the plates. These plates were incubated at 37 C
for about 48 h in a humid chamber [34]. Following this, zone
inhibition diameters were observed and measured carefully.
2.4. Docking study
The high resolution crystal structure of Enoyl-ACP reductase
was downloaded from the RCSB PDB website (PDB ID:
1QG6) [35]. All molecular docking calculations were per-
formed on Auto Dock-Vina software [36]. The protein was
prepared for docking by removing the co-crystallized ligands,
waters and co-factors. The AutoDockTools (ADT) graphical
user interface was used to calculate Kollman charges and polar
hydrogens. The ligand was prepared for docking by min-
imising its energy with MMFF94 s force ﬁeld. Partial charges
were calculated by Geistenger method. The active site of the
enzyme was deﬁned to include residues of the active site within
the grid size of 40 A˚  40 A˚  40 A˚. The most popular algo-
rithm, Lamarckian Genetic Algorithm (LGA) available in
Autodock was employed for docking. The docking protocol
was tested by extracting co-crystallized an inhibitor from the
protein and then docking the same. The docking protocol pre-
dicted the same conformation as was present in the crystal
structure with RMSD value well within the reliable range of
<1 A˚ (Fig. 1). Amongst the docked conformations, one whichprotocol.
hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
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tions in Discover Studio Visualizer 4.
3. Results and discussion
3.1. Synthesis
To the best of our knowledge, this new synthetic strategy pro-
vides the ﬁrst example of a facile three component protocol for
the preparation of novel 2-(1H-indol-3-ylmethyl)-5,5-dime
thyl-cyclohexane-1,3-diones (4a–l). To get the best experimen-
tal conditions, the reaction conditions were optimised for the
preparation of 4a chosen as model reaction for both at room
temperature and at reﬂux conditions. As depicted in Scheme 1
indole and dimedone as reacting materials were treated with
different aldehydes. A number of solvents in the presence of
a variety of catalysts (with/without suitable additive) were
employed to design a desirable reaction medium. Initially
dichloroethane (DCE), a nonpolar solvent in the presence of
anh.FeCl3 furnished 4a with poor yield including prolonged
reaction time (Table 1; entry; 1, 23%) [25]. Afterwards, reac-
tion was performed in solvents like dimethyl sulphoxide
(DMSO), acetonitrile (ACN), tetrahydrofuran (THF/HOH)
and dimethyl formamide (DMF) using different metal cata-
lysts like CuI/K2CO3, KO
tBu, Li(OH)2, and Cs2CO3. It was
observed that the product yield was obtained in 9%, 18%,
11%, 14%, and 23% (Table 1; entry 2–6) but prolonged reac-
tion time was still a challenge [9,37,38,19,39]. Inspired by these
results the reaction was then carried in more polar solvents like
methanol (MeOH), ethanol (EtOH/HOH), acetic acid (AcOH)Table 1 Optimised catalyst (or additives) and solvent effects on the
methyl]-5,5-dimethyl-cyclohexane-1,3-dione (4a).
Entry Solvent Additive Catalyst
1 DCE – Anh.FeCl3
2 DMSO K2CO3 CuI
3 DMSO KOtBu
4 ACN – –
5 THF/HOH – Li(OH)2
6 DMF – Cs2 CO3
7 MeOH – –
8 MeOH – Anh.ZnCl2
9 EtOH/HOH – DMAP
10 EtOH – Dibutylamine
11 AcOH – –
12 HOH – PEG/OSO3H
13 HOH – mpCuO
PReﬂux condition, Qroom temperature.
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dimethylaminopyridine (DMAP), dibutylamine and
PEG/OSO3H. In this context, the reaction occurred smoothly
and improved product yield as well as reaction time. As a
result we were able to isolate the product yield at 27%, 33%,
43%, 57%, 43% and 55% (Table 1; entry; 7–12) [40–45].
Finally, water was taken as a best medium choice which in
the presence of a suitable catalyst mpCuO (Table S1, 4 mol
%) afforded 4a (Table 1; entry 13, 93%) in highest yield than
all other solvents. It is evident that amongst these catalysts,
mpCuO give the better results. Besides interesting features
regarding high surface area, nice porosity, moisture stability,
the better catalytic activity of mpCuO may also be attributed
to high proportion of structural defects and minimal coordi-
nated sites on its surface [46,47].
The plausible mechanism (Scheme 2) explaining the afore-
mentioned results assumes that mpCuO coordinates to the car-
bonyl oxygen of aldehyde and facilitates its reaction with
dimedone via Knoevenagel type coupling results in the forma-
tion of a, b-unsaturated ketone 6. Coordination of mpCuO to
ﬁrst formed Knoevenagel product 6 activates it towards nucle-
ophilic addition of indole at its C(3) position to afford the
intermediate 7. Finally, there occurs electron reorganization
in 7 accompanied with H-transfer to afford desirable com-
pound 4, acquitting the catalyst for the next cycle (see Table 2).
The reusability of the catalysts broadens their area of
potential applications. It is pertinent to mention that the
mpCuO was found to exhibit almost same catalytic activity
only showing a slight variation in reaction rate and % yield
of desired product. It may be due to coagulation of the nanoreaction rate and % yield of 2-[(4-chloro-phenyl)-(1H-indol-3-yl)-
Time (h) % Yield Refs.
P 11 23 [25]
Q – –
P 10 9 [9]
Q – –
P 15 18 [37]
Q – –
P 19 11 [38]
Q – –
P 13 14 [19]
Q 19 13
P 9 23 [39]
Q – –
P 7 27 [40]
Q 12 18
P 5 33 [41]
Q 10 31
P 4 43 [42]
Q 11 38
P 5 57 [43]
Q 11 49
P 9 43 [44]
Q 14 16
P 8 55 [45]
Q – –
P 0.33 93 Present work
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Scheme 2 The plausible mechanism for one pot synthesis of 2-(1H-indol-3-ylmethyl)-5,5-dimethyl-cyclohexane-1,3-diones (4a–l).
Table 2 Water mediated one pot synthesis of 2-(1H-indol-3-ylmethyl)-5,5-dimethyl-cyclohexane-1,3-diones (4a–l).
Entry R R0 Protocol Time (min) Product (%) Yield isolated m.p. (C)
1 p-ClC6H5 H P 20 4a 93 133–136
2 C6H5 H P 15 4b 91 141–144
3 m-NO2C6H5 H P 23 4c 85 139–142
4 p-NO2C6H5 H P 20 4d 89 127–130
5 p-OMeC6H5 H P 22 4e 95 152–155
6 CH3 H P 17 4f 82 135–138
7 p-ClC6H5 Br P 23 4g 90 146–149
8 C6H5 Br P 19 4h 83 139–142
9 m-NO2C6H5 Br P 27 4i 85 126–129
10 p-NO2C6H5 Br P 23 4j 88 162–165
11 p-OMeC6H5 Br P 31 4k 91 169–172
12 CH3 Br P 20 4l 78 144–147
PRoom temperature.
Figure 2 Reusability of the catalyst mpCuO.
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alyst used (Fig. 2). The catalyst recovered above was added to
the aqueous phase containing the same reactants. The experi-
ments were repeated for four times and the products were iden-
tiﬁed by their melting points and IR spectra. As indicated in
the Fig. 2, the catalyst can be used more than ﬁve times with-
out a signiﬁcant drop in product yield.
The synthesised compounds 4a–l were characterised by dif-
ferent spectral techniques like IR, NMR and HRLCMS. IR
spectrum of compound 4a exhibited sharp bands at 822 cm1
and 1320 cm1 assigned to C–Cl and C–N is stretching fre-
quencies respectively. The band at 1717 cm1 indicated the
presence of dimedone carbonyl whereas aromatic C–H stretch-
ing was observed at 3045 cm1. In 1H NMR spectrum of 4a
four singlets due to protons of C15/16-CH3, C12/14-CH2,hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
Figure 3 The docked ligand (pink) binds at the same site where
co-crystallized triclosan (green) binds.
3-Alkylated indole derivatives as antitubercular agents 7C10-CH and C9-CH were recorded at 1.2, 2.4, 3.7 and 4.6 d
ppm. The proton at C70-position shows a singlet at 6.3 d
ppm where as resonance emission of protons at C10 and C20
positions appeared as two double doublets at 7.0 and, 7.2 d
ppm. The rest of the proton signals were recorded in the
expected regions. Also 13C NMR of compound 4a agrees with
the number of carbons. It exhibited signals around 17–81 d
ppm attributed to methyl, methylene and methine carbon
atoms. Peaks between 109–143 d ppm were assigned to aro-
matic carbon atoms and a peak at 169 d ppm might be due
to dimedone carbonyl atom. The unambiguous conﬁrmation
of 4a was done from its mass spectra exhibited the molecularFigure 4 Schematic representation for the docked conformation of th
by Ligplus.
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molecular weight of the compound (Supplementary S7–S9).
3.2. Docking study
Docking study reveals that the synthesised molecules bind at
the same site where the co-crystallized drug Triclosan is
attached. (Fig. 3) Ser91 and Thr194 form H-bonds of length
2.84 and 2.78 A˚ respectively with 4k, the highest scoring mole-
cule (Fig. 4). These interactions along with other prominent
interactions are described in (Fig. 5). The interactions pre-
dicted by docking study suggest a strong ligand-
macromolecule complex. These ﬁndings reveal that the syn-
thesised molecules possess high afﬁnity towards bacterial
Enoyl-ACP reductase. Binding afﬁnity values of greater than
9 kcal/mol for all the ligand-ACP-reductase complexes cor-
roborates the above conclusion (Table S2). Compound 4e, 4f
and 4a follow compound 4k in docking score. The computa-
tional predictions were complemented by the in vitro antituber-
cular activity values.
As is evident from Table 3, compound 4d, 4e, 4j and 4k are
able to inhibit the bacterial strain to appreciable levels with
respective MIC values of 60, 15, 15 and 60 lg/mL in compar-
ison to Isoniazid taken as standard against Mycobacterium
tuberculosis. However the rest of the tested compound showed
MIC values ranging from 90 to >180 lg/mL (Table 3). In gen-
eral the methoxy and nitro derivatives show better activity as
compared to chloro, methyl and benzyl derivatives. The reason
behind the observed activity trend seems to be the way in
which the molecules bind at the target active site as is predicted
by docking (Figs. 1 and 3). The compound 4k shows better
inhibition than all other compounds at the same
concentrations.e ligand 4k at the active site of Enoyl-ACP reductase constructed
hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
Table 3 Lipscomb’s parameters, binding afﬁnity and diameter of zone of inhibition (mm) for 2-(1H-indol-3-ylmethyl)-5,5-dimethyl-
cyclohexane-1,3-diones (4a–l).
Compound code Binding aﬃnity clogP H-bond donors H-bond acceptors Molecular weight Zone of Inhibition (mm)*
4a 9.5 5.4453 1 2 380.13 17.31 ± 0.17 >180
4b 9.2 5.9443 1 2 346.18 15.84 ± 0.16 >180
4c 9.3 6.4733 1 3 391.17 11.54 ± 0.38 >180
4d 9.0 6.3291 1 3 391.17 22.11 ± 0.03 60
4e 9.9 5.5543 1 3 376.19 24.39 ± 0.26 30
4f 9.6 5.5543 1 2 284.17 21.38 ± 0.04 90
4g 9.6 3.4713 1 2 460.09 18.27 ± 0.06 >180
4h 9.3 3.9704 1 2 424.09 20.75 ± 0.10 180
4i 9.2 4.4993 1 3 470.08 14.19 ± 0.01 >180
4j 9.2 4.3551 1 3 470.08 23.08 ± 0.03 60
4k 10.1 3.5803 1 3 454.10 25.14 ± 0.06 15
4l 9.0 3.5803 1 2 362.08 20.68 ± 0.07 90
Isoniazid 7.3 0.69 2 2 137.14 25.70 ± 0.05 10
* Average of three.
Figure 5 Detailed interactions of 4k with the inhibitor residues. Dotted lines represent the interactions. H bonds, p–p stacking and
alkyl–p interactions are represented by green, pink and violet dotted lines respectively.
8 G.A. Khan et al.4. Conclusion
Here we report the fusion of benign aqueous medium and
nano-catalyst to develop a mild and green approach with
higher environmental sustainability for the synthesis of novel
2-(1H-indol-3-ylmethyl)-5,5-dimethyl-cyclohexane-1,3-diones
employing a MCR protocol. Operational simplicity, reduced
reaction times, better functional group tolerance, excellentPlease cite this article in press as: G.A. Khan et al., Porous CuO catalysed green synt
of Saudi Chemical Society (2016), http://dx.doi.org/10.1016/j.jscs.2016.03.009yields and ease of product isolation are the advantageous fea-
tures encountered which makes the present methodology as
desirable. Attractive features of mpCuO are high catalytic efﬁ-
ciency, maximum surface area and recyclability. In vitro antitu-
bercular evaluation has veriﬁed that compounds (4a-l) can be
used to generate a library of antitubercular analogues which
can exhibit better selectivity. Indeed, docking studies corrobo-
rate to the in vitro results as well.hesis of some novel 3-alkylated indoles as potent antitubercular agents, Journal
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